Department of Pediatrics, University of Kuopio and Kuopio University Hospital, PO Box 1777, FI-70211 Kuopio, Finland.
Eur J Endocrinol. 2010 Mar;162(3):551-7. doi: 10.1530/EJE-09-1003. Epub 2009 Dec 17.
Altered glucocorticoid activity is one possible mechanism linking fetal growth restriction with later insulin resistance (IR) and type 2 diabetes. We aimed to investigate whether serum glucocorticoid parameters are related to IR in children born small for gestational age (SGA).
A total of 110 children (55 age- and gender-matched pairs born SGA or appropriate for gestational age (AGA) in a case-control setting) were studied at the mean age of 12.2 (s.d. 0.2) years.
Serum cortisol, corticosteroid-binding globulin (CBG), free cortisol index (FCI=cortisol/CBG), and glucocorticoid bioactivity (GBA, transactivation assay) were analyzed and related to serum adiponectin and insulin-like growth factor-binding protein 1 (IGFBP1) concentrations and homeostasis model assessment for IR (HOMA-IR) and QUICKI indices.
In the pooled study population, GBA correlated well with cortisol and FCI (r=0.681 and 0.586 respectively; P<0.001 for both). Serum cortisol, CBG, FCI, GBA, HOMA-IR, or QUICKI did not differ between the SGA and AGA subjects, but the SGA children had lower body mass index (P=0.005) and waist circumference (WC) (P=0.001). The mean GBA in the highest GBA quartile was higher among the SGA subjects than among the AGA subjects (138.6 vs 96.4 nmol/l cortisol equivalents, P<0.001). In the SGA children, GBA correlated positively with HOMA-IR (r=0.522, P<0.001) and inversely with adiponectin (r=-0.278, P=0.042) (WC/height ratio adjustments), and in logistic regression analysis, higher GBA (odds ratio (OR) 1.3; P=0.013), lower adiponectin (OR 1.4; P=0.038), and lower IGFBP1 (OR 1.9; P=0.010) associated independently with higher HOMA-IR.
These findings suggest that increased glucocorticoid activity and low serum adiponectin concentrations associate with IR in SGA children.
糖皮质激素活性的改变是将胎儿生长受限与以后的胰岛素抵抗(IR)和 2 型糖尿病联系起来的一种可能机制。我们旨在研究在出生体重小于胎龄(SGA)的儿童中,血清糖皮质激素参数是否与 IR 相关。
在病例对照研究中,共研究了 110 名儿童(55 对年龄和性别匹配的 SGA 或适合胎龄(AGA)儿童),平均年龄为 12.2(标准差 0.2)岁。
分析了血清皮质醇、皮质类固醇结合球蛋白(CBG)、游离皮质醇指数(FCI=皮质醇/CBG)和糖皮质激素生物活性(GBA,转导测定),并与血清脂联素和胰岛素样生长因子结合蛋白 1(IGFBP1)浓度以及胰岛素抵抗评估的稳态模型(HOMA-IR)和 QUICKI 指数相关。
在汇总研究人群中,GBA 与皮质醇和 FCI 相关性良好(r=0.681 和 0.586,P<0.001)。SGA 和 AGA 受试者之间的血清皮质醇、CBG、FCI、GBA、HOMA-IR 或 QUICKI 没有差异,但 SGA 儿童的体重指数(P=0.005)和腰围(WC)(P=0.001)较低。GBA 最高四分位数的 SGA 受试者的 GBA 平均值高于 AGA 受试者(皮质醇当量 138.6 与 96.4 nmol/L,P<0.001)。在 SGA 儿童中,GBA 与 HOMA-IR 呈正相关(r=0.522,P<0.001),与脂联素呈负相关(r=-0.278,P=0.042)(WC/身高比调整),在逻辑回归分析中,较高的 GBA(比值比(OR)1.3;P=0.013)、较低的脂联素(OR 1.4;P=0.038)和较低的 IGFBP1(OR 1.9;P=0.010)与 HOMA-IR 独立相关。
这些发现表明,SGA 儿童的糖皮质激素活性增加和血清脂联素浓度降低与 IR 相关。